Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians

British Journal of Biomedical Science

Volumn 68, Issue 3, 2011, Pages 138-142

  Akinloye, O ^a,b   Gromoll, J ^a   Simoni, M ^a,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Haplotypes; Prostatic neoplasms; Receptors, androgen

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN; MICROSATELLITE DNA;

ADULT; ARTICLE; CAG REPEAT; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; DNA STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GGN REPEAT; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; AGED; CARCINOMA; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PROSTATE TUMOR;

AGED; CARCINOMA; CASE-CONTROL STUDIES; HAPLOTYPES; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NIGERIA; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 80054084335     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2011.11730341     Document Type: Article

References (26)

1. Ogunbiyi JO, Shittu OB. Increased incidence of prostate cancer in Nigerians. J Natl Med Assoc 1999; 91 (3): 159-64.
2. Vijayalakshmi K, Thangaraj K, Rajender S et al. GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men. J Hum Genet 2006; 51 (11): 998-1051.
3. Lu S, Tsai SY, Tsai MJ. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI P16 genes. Cancer Res 1997; 57: 4511-6. (Pubitemid 27441054)
4. Zeegers MP, Kiemeney LA, Nieder AM, Ostrer H. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 2004; 13 (11): 1765-71. (Pubitemid 39482954)
5. Chamberlain N, Driver E, Miesfeld R. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acid Res 1994; 22: 3181-6. (Pubitemid 24260654)
6. Mishra DK, Thangaraj K, Mandhani A, Kumar A, Mittal RD. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet 2005; 68: 55-60. (Pubitemid 40867539)
7. Ann W. Hsing,1 Gao YT et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 2000; 60: 5111-6.
8. Stanford JL, Just JJ, Gibbs M et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997; 57: 1194-8. (Pubitemid 27138622)
9. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 1997; 3: 1599-608.
10. Platz EA, Giovannucci E, Dahl DM et al. The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomark Prev 1998; 7: 379-84. (Pubitemid 28354125)
11. Jackson MA, Kovi J, Heshmat MY et al. Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. Prostate 1980; 1 (2): 185-205.
12. Giovannucci E, Stampfer MJ, Krithivas K et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997; 94: 3320-3. (Pubitemid 27157309)
13. Ingles SA, Ross RK, Yu MC et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997; 89: 166-70. (Pubitemid 27034793)
14. Kittles RA, Young D, Weinrich S et al. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Hum Genet 2001; 109: 253-61. (Pubitemid 32926918)
15. Kantoff P, Giovannucci E, Brown M. The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer. Biochim Biophys Acta 1998; 1378: C1-C5. (Pubitemid 28552778)
16. Correa-Cerro L, Wohr G, Haussler J et al. (CAG)nCAA, and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 1999; 7: 357-62. (Pubitemid 29213742)
17. Tayeb MT, Clark C, Murray GI, Sharp L, Haites NE, McLeod HL. Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia. Ann Saudi Med 2004; 24 (1): 21-6. (Pubitemid 38195601)
18. Choong CS, Kemppainen JA, Zhou ZX, Wilson EM. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 1996; 10 (12): 1527-35. (Pubitemid 26408742)
19. Bousema JT, Bussemakers MJ, van Houwelingen KP et al. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol 2000; 37: 234-8. (Pubitemid 30103079)
20. Giovannucci E, Stampfer MJ, Chan A et al. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in US physicians. Prostate 1999; 39: 130-4. (Pubitemid 29194285)
21. Giovannucci E, Platz EA, Stampfer MJ et al. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 1999; 53: 121-5. (Pubitemid 29016626)
22. Mitsumori K, Terai A, Oka H et al. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate 1999; 41: 253-7.
23. Shibata A, Stamey TA, McNeal JE, Cheng I, Peehl DM. Genetic polymorphisms in the androgen receptor and type II 5a-reductase genes in prostate enlargement. J Urol 2001; 166: 1560-4. (Pubitemid 32862238)
24. Lange EM, Sarma AV, Ray A et al. The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study. J Hum Genet 2008; 53 (3): 220-6.
25. Mittal RD, Mishra DK, Thangaraj K, Singh R, Mandhani A. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population? Steroids 2007; 72: 335-41. (Pubitemid 46452712)
26. Wright JL, Lange PH. Newer potential biomarkers in prostate cancer. Rev Urol 2007; 9 (4): 207-13.